600196.SH
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 22.79
−3.27%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- CNY 0.35
- Revenue estimate
- CNY 10.3B
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- CNY 0.32
- EPS estimate
- CNY 0.36
- Revenue actual
- CNY 10.2B
- Revenue estimate
- CNY 10.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -11.1%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 25, 2026 | CNY 0.36 | CNY 0.32 | Miss -11.12% | CNY 10.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 29, 2027